Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: a Review of Risk Factors and Current Approaches to Diagnosis and Management
Prevention, early identification, and effective management of periprosthetic joint infection (PJI) in patients with inflammatory joint disease (IJD) present unique challenges for physicians. Discontinuing disease-modifying anti-rheumatoid drugs (DMARDs) perioperatively may reduce immunosuppression and infection risk at the expense of increasing disease flares. Interpreting traditional diagnostic markers of PJI can be difficult due to disease-related inflammation.
This review is designed to answer how to (1) manage immunosuppressive/DMARD therapy perioperatively, (2) diagnose PJI in patients with IJD, and (3) treat PJI in this population.
The PubMed database was searched for relevant articles with subsequent review by independent authors.
While there is evidence to support the use of methotrexate perioperatively in RA patients, it remains unclear whether using anti-tumor necrosis factor medications perioperatively increases the risk of surgical site infections. Serum erythrocyte sedimentation rate and C-reactive protein can be useful for diagnosis of PJI in this population, but only as part of comprehensive workup that ultimately relies upon sampling of joint fluid. Management of PJI depends on several clinical factors including duration of infection and the likelihood of biofilm presence, the infecting organism, sensitivity to antibiotic therapy, and host immune status. The evidence suggests that two-stage revision or resection arthroplasty is more likely to eradicate infection, particularly when MRSA is the pathogen.
Immunosuppression and baseline inflammatory changes in the IJD population can complicate the prevention, diagnosis, and treatment of PJI. Understanding the increase in risk associated with IJD and its treatment is essential for proper management when patients undergo lower extremity arthroplasty.
- Au K, Reed G, Curtis J, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:785-791. CrossRef
- Baré J, Macdonald S, Bourne R. Preoperative Evaluations in Revision Total Knee Arthroplasty. Clin Orthop. 2006;446:40-44.
- Berbari EF, Osmon D, Duffy MC, et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis. 2006;42:216-223. CrossRef
- Bernard L, Lübbeke A, Stern R, et al. Value of peroperative investigation in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scan J Infect Dis. 2004;36:410-416. CrossRef
- Bongartz T, Halligan C, Osmon D, et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008;59:1713-1720. CrossRef
- Breidahl WH, Newman JS, Taljanovic MS, Adler RS. Power Doppler sonography in the assessment of musculoskeletal fluid collection. Am J Roentgenol. 1996;166(6):1444-1446. CrossRef
- Cipriano CA, Brown NM, Michael AM, Moric M, Sporer SM, Della VC. Serum and synovial fluid analysis for diagnosing chronic periprosthetic infection in patients with inflammatory arthritis. J Bone Joint Surg Am. 2012;94:594-600. CrossRef
- Da Cunha B, Maria Henrique Da Mota L, Dos Santos-Neto L. Risk of orthopedic surgical site infections in patients with rheumatoid arthritis treated with antitumor necrosis factor alpha therapy. Int J Rheumatol. 2012;2012:1-5. CrossRef
- Della Valle C, Parvizi J, Bauer TW, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee. J Bone Joint Surg Am. 2011;93:1355-1357. CrossRef
- Della Valle CJ, Sporer SM, Jacobs JJ, Berger RA, Rosenberg AG, Paprosky WG. Preoperative testing for sepsis before revision total knee arthroplasty. J Arthroplasty. 2007;22:90-93. CrossRef
- Fahlén A, Engstrand L, Baker BS, Powles A, Fry L. Comparison of bacterial microviota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012;304(1):15-22. CrossRef
- Garcia R, Hardy B, Kraay M, Goldberg V. Revision total knee arthroplasty for aseptic and septic causes in patients with rheumatoid arthritis. Clin Orthop. 2010;468:82-89. CrossRef
- Gardner J, Gioe TJ, Tatman P. Can this prosthesis be saved? Implant salvage attempts in infected primary TKA. Clin Orthop. 2011;469(4):970-976. CrossRef
- Greidanus N, Masri B, Garbuz D, et al. Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty. A prospective evaluation. J Bone Joint Surg. 2007;89:1409-1416. CrossRef
- Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001;60:214-217. CrossRef
- Hirao M, Hashimoto J, Tsuboi H, et al. Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab. Ann Rheum Dis. 2009;68:654-657. CrossRef
- Kersey R, Benjamin J, Marson B. White blood cell counts and differential in synovial fluid of aseptically failed total knee arthroplasty. J Arthroplasty. 2000;15:301-304.
- Kim Y, Choi Y, Kim J. Treatment based on the type of infected TKA improves infection control. Clin Orthop. 2011;469:977-984. CrossRef
- Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012; 27: 61–5.e1
- Mason JB, Fehring T, Odum S, Griffin WL, Nussman DS. The value of white blood cell counts before revision total knee arthroplasty. J Arthroplasty. 2003;18:1038-1043.
- Menon TJ, Wroblewski BM. Charnley low-friction arthroplasty in patients with psoriasis. Cli Orthop Relat Res. 1983;176:127-128.
- Momohara S, Hashimoto J, Tsuboi H et al. Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study. Mod Rheumatol. 2012; doi: 10.1007/s10165-012-0683-0
- Momohara S, Kawakami K, Iwamoto T, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011;21:469-475. CrossRef
- Musculoskeletal Infection Society Workgroup. New definition for periprosthetic joint infection. J Arthroplasty. 2011;26:1136-1138. CrossRef
- Ranganath VK, Elashoff DA, Khanna D, et al. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol. 2005;32:1040-1042.
- Saag K, Teng G, Patkar N, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59:762-784. CrossRef
- Scanzello C, Figgie M, Nestor B, Goodman S. Perioperative management of medications used in the treatment of rheumatoid arthritis. HSS J. 2006;2:141-147. CrossRef
- Schinsky M, Della Valle C, Sporer S, Paprosky W. Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty. J Bone Joint Surg. 2008;90:1869-1875. CrossRef
- Schrama J, Espehaug B, Hallan G, et al. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res. 2010;62:473-479. CrossRef
- Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am. 1999;81:1434-1445.
- Sendi P, Banderet F, Graber P, Zimmerli W. Clinical comparison between exogenous and haematogenous periprosthetic joint infections caused by Staphylococcus aureus. Clin Microbiol Infect. 2011;17:1098-1100. CrossRef
- Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am. 1999;81:672-683.
- Sreekumar R, Gray J, Kay P, Grennan DM. Methotrexate and post operative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery—a ten year follow-up. Acta Orthop Belg. 2011;77:823-826.
- Stern SH, Insall JN, Windsor RE, Inglis AE, Dines DM. Total knee arthroplasty in patients with psoriasis. Clin Orthop Relat Res. 1989;248:108-110.
- Tattevin P, Crémieux AC, Pottier P, Huten D, Carbon C. Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis. 1999;29:292-295. CrossRef
- Trampuz A, Hanssen A, Osmon D, Mandrekar J, Steckelberg JM, Patel R. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med. 2004;117:556-562
- Yildirim K, Erdal A, Karatay S, Melikoğlu MA, Uğur M, Senel K. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis. South Med J. 2004;97:350-353. CrossRef
- Yildirim K, Karatay S, Melikoglu MA, Gureser G, Ugur M, Senel K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci. 2005;34:423-426.
- Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: a Review of Risk Factors and Current Approaches to Diagnosis and Management
HSS Journal ®
Volume 9, Issue 2 , pp 183-194
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- periprosthetic joint infection
- inflammatory arthritis
- total joint arthroplasty
- Industry Sectors
- Author Affiliations
- 1. Jefferson Medical College, 1025 Walnut Street, Philadelphia, PA, 19107, USA
- 2. Department of Orthopedic Surgery, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA
- 3. Division of Infectious Diseases, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA
- 4. Department of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA